Objectives: To determine the incidence of sleep disturbances, including insomnia in healthcare professionals dealing with COVID-19 patients. Methodology: A cross-sectional study was conducted at inpatient infectious disease units, emergency department and ICU (for COVID-19 patients), at the Pakistan Institute of Medical Sciences (PIMS) from February 2022 to April 2022. All the individuals participating in the study were healthcare professionals. Insomnia Severity Index was used for the questionnaire. The scores of the surveyed subjects were calculated and the characteristic demographics of the subjects were analyzed. Results: An upward trend in the incidence of poor sleep quality was noted among the healthcare professionals who participated in this study. Out of 160 healthcare professionals, 93(58.1%) of the population was females, while 67(41.9%) were males. The majority of participants (p<0.05) were between the ages of 20 and 30 years, followed by 31 to 40 years and 41 to 50 years. A significant proportion of the population (p<0.05) belonged to the unmarried group, followed by the married, separated, and divorced with a percentage of 60.6, 36.2, 2.5 and 0.6%, respectively. Moreover, 84.4% (135/160) of healthcare professionals (p<0.05) had a previous history of sleep disorders. Insomnia Severity Index (ISI) score system was used to analyze the intensity of sleep disorders and insomnia in the affected persons and it was found that most of the participants were diagnosed with subthreshold insomnia (38.8%). Conclusion: The study elucidated that there was a significantly higher incidence of sleep disturbances and insomnia, in healthcare professionals working in Covid-19 care units.

We present frequency of ocular symptoms in COVID-19 patients in Pakistan Institute of Medical Sciences (PIMS), Islamabad. A total of 333 admitted patients with laboratory-confirmed SARS-CoV-2 infection were included. Patients were enquired and examined for any ocular symptoms that developed along with COVID-19. The results were stratified by sex, age, comorbidities, High Resolution CT (HRCT) and condition of conjunctiva. Data was analyzed using SPSS 28.0.1.1. Chi square test was performed to measure the p value of the reported eye symptoms. Out of the 333, 81 subjects fulfilled the inclusion criteria. Forty-six patients (56%) were females and 52 patients out of 81 (64.2%) reported redness of conjunctiva. A positive relationship between the COVID-19 and the frequency of eye symptoms was observed with p value of 0.001. A weak positive correlation between HRCT and conjunctiva was found through bivariate analysis (0.132).